Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by SAGDollaron Dec 11, 2020 9:05pm
182 Views
Post# 32091870

RE:Soo..

RE:Soo.. This is the last time il mention MindMed, MMED. I don't want to spam this board, but I want to pass on what was passed on to me early this week. Psychedelic Industry is on fire this week and the pincial is MMED. Coming from someone who has depression and addiction run in their family it hits close to home. As we all know the world isn't in the best place currently and just like cancer, depression and addiction is a disease. The opoid crisis and suicides are at all time highs, and I like to thing this company can really make a drastic impact on minimazing ruined life's and sleepless nights. I like investing in company's that make the world a better place, which is one of the things I like about SZLS. A strong passion to make the world better for the average joe. 

My end goal here isn't to recuirt any one or steal attention off SZLS. Im beyond excited for Q1, however I know a lot of people are in the red or close to it here after the disappointing market reaction to the achieved milestones that SZLS has recently conquered. I hope that maybe a few of y'all will look in to this company and make some losses back in a short period of time.  The psychedelic industry was on fire this week It will likely have a much larger market reaction and hold more validity and medicinal effectiveness than marijuana. 

After all we are here to make money and with future up listing of MMED to NASDAQ just around the corner it could be huge. Easy 2-3x bagger short term Imo. I plan on taking some of my future profits from MMED and putting it in SZLS come January before this lights off. Below is a great brief read about MMED where it's been claimed to be the "tesla of the mental health" which is currently back by Kevin Oleary. 


https://m.benzinga.com/article/18733073


Cheers. 

SAGDollar. 
<< Previous
Bullboard Posts
Next >>